Special presentation: Learn how 'cheaping out,' building in discipline, and other simple steps help successful investors get it done.
The improving housing market will be a key contributor to growth in 2015, says Morningstar's Bob Johnson.
The Templeton Global manager discusses recent Europe bond volatility, the outlook for the dollar and emerging markets, plus the need for a dynamic approach to international bonds.
Total non-residential-construction spending is likely to disappoint over the next decade, but growth in construction-heavy industries like manufacturing and highways bodes well for some companies.
Why they're attractive, the four variations, and why investors should take a strategic rather than a tactical approach with these funds.
We dig into recent performance, the role of reforms, and concentration issues with some emerging-markets indexes.
Seafarer manager Andrew Foster has outpaced sluggish developing-world markets over the last three years by seeking stable growers.
IShares MSCI USA Quality Factor ETF targets large and mid-sized U.S. businesses with durable competitive advantages and strong balance sheets.
First movers and firms that provide combination therapies represent the best investment opportunities in the immuno-oncology market, says Morningstar's Damien Conover.
The fact that the Fed minutes were a non-event this week is a good sign for its communication policy. Plus, Wal-Mart shares a good buy for the patient, and more.
Narrow-moat Priceline should increase its market share substantially in the coming years, and shares trade at a discount.
European multinationals are still some of the cheapest companies in the global universe today, says the Oakmark International manager.
©2014 Morningstar Advisor. All right reserved.